BiVictriX Therapeutics secures US patent for cancer therapy

BiVictriX Therapeutics secures US patent for cancer therapy BVX001

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) said that the United States Patent and Trademark Office (USPTO) has approved a patent for its primary cancer...

Related Keywords

Japan , United States , Japanese , , Japanese Patent Office , Trademark Office , Bivictrix Therapeutics , United States Patent , Tiffany Thorn ,

© 2024 Vimarsana